A general strategy to optimize immunogenicity of HLA-B*0702 restricted cryptic peptides from tumor associated antigens: Design of universal neo-antigen like tumor vaccines for HLA-B*0702 positive patients.
about
A general strategy to optimize immunogenicity of HLA-B*0702 restricted cryptic peptides from tumor associated antigens: Design of universal neo-antigen like tumor vaccines for HLA-B*0702 positive patients.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
A general strategy to optimize ...... HLA-B*0702 positive patients.
@en
A general strategy to optimize ...... HLA-B*0702 positive patients.
@nl
type
label
A general strategy to optimize ...... HLA-B*0702 positive patients.
@en
A general strategy to optimize ...... HLA-B*0702 positive patients.
@nl
prefLabel
A general strategy to optimize ...... HLA-B*0702 positive patients.
@en
A general strategy to optimize ...... HLA-B*0702 positive patients.
@nl
P2093
P2860
P356
P1433
P1476
A general strategy to optimize ...... HLA-B*0702 positive patients.
@en
P2093
Aude Rougeot
Catherine Gallou
Jeanne Menez-Jamet
Kostas Kosmatopoulos
P2860
P304
59417-59428
P356
10.18632/ONCOTARGET.11086
P407
P577
2016-08-05T00:00:00Z